EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 26 / Numéro 11 (Novembre 2010) Med Sci (Paris), 26 11 (2010) 950-959 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 11, Novembre 2010
Page(s) 950 - 959
Section Resistance aux antibiotiques : un enjeu international
DOI https://doi.org/10.1051/medsci/20102611950
Publié en ligne 15 novembre 2010
  1. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 2005 ; 18 : 306-25. [Google Scholar]
  2. Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 2009 ; 69 : 1879-901. [Google Scholar]
  3. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumonia carbapenemase-producing bacteria. Lancet Infect Dis 2009 ; 9 : 228-36. [Google Scholar]
  4. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007 ; 2 : 501-12. [Google Scholar]
  5. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007 ; 20 : 440-58. [Google Scholar]
  6. Rossolini GM, Mantengoli E, Docquier JD, et al. Epidemiology of infections caused by multiresistant gram-negatives: ESBL, MBL, panresistant strains. New Microbiol 2007 ; 30 : 332-9. [Google Scholar]
  7. Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 2008 ; 14 (Suppl 1) : 82-9. [Google Scholar]
  8. Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009 ; 63 : 659-67. [Google Scholar]
  9. Lee K, Yong D, Choi YS, et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007 ; 29 : 201-6. [Google Scholar]
  10. Lartigue MF, Poirel L, Poyart C, et al. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007 ; 13 : 315-7. [Google Scholar]
  11. Carmeli Y, Akova M, Cornaglia G, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010 ; 16 : 102-11. [Google Scholar]
  12. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008 ; 52 : 1028-33. [Google Scholar]
  13. Miriagou V, Cornaglia G, Edelstein M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010 ; 16 : 112-22. [Google Scholar]
  14. Samra Z, Bahar J, Madar-Shapiro L, et al. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2008 ; 46 : 3110-1. [Google Scholar]
  15. Carrër A, Poirel L, Yilmaz M, et al. Emerging spread of OXA-48-encoding plasmid from Turkey and beyond. Antimicrob Agents Chemother 2010 ; 54 :1369-73. [Google Scholar]
  16. Gülmez D, Woodford N, Palepou MF, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008 ; 31 : 523-6. [Google Scholar]
  17. Uzun O, Hascelik G, Livermore DM. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008 ; 31 : 523-6. [Google Scholar]
  18. Poirel L, Héritier C, Nordmann P. Chromosome-encoded ambler class D β-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob Agents Chemother 2004 ; 48 : 348-51. [Google Scholar]
  19. Walsh TR. Clinically significant carbapenemases: an update. Curr Opin Infect Dis 2008 ; 21 : 367-71. [Google Scholar]
  20. Lartigue MF, Poirel L, Nordmann P. First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob Agents Chemother 2004 ; 48 : 4929-30. [Google Scholar]
  21. Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L. VIM-19, a metallo-β-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob Agents Chemother 2010 ; 54 : 471-6. [Google Scholar]
  22. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-β-lactamase gene, b/a(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009 ; 53 : 5046-54. [Google Scholar]
  23. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010 ; 10 : 597-602. [Google Scholar]
  24. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 2009 ; 58 : 1133-48. [Google Scholar]
  25. Mesaros N, Nordmann P, Plésiat P, et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 2007 ; 13 : 560-78. [Google Scholar]
  26. Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2002 ; 50 : 673-9. [Google Scholar]
  27. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009 ; 53 : 4783-8. [Google Scholar]
  28. Nordmann P, Poirel L. Acinetobacter baumannii: Basic and emerging mechanisms of resistance. Eur Infect Dis 2009 ; 2 : 94-7. [Google Scholar]
  29. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010 ; 54 : 24-38. [Google Scholar]
  30. Higgins PG, Poirel L, Lehmann M, et al. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009 ; 53 : 5035-8. [Google Scholar]
  31. Towner KJ. Acinetobacter : an old friend, but a new enemy. J Hosp Infect 2009 ; 73 : 355-63. [Google Scholar]
  32. Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram- negative pathogenic bacteria: β-lactams in peril! Curr Opin Microbiol 2005 ; 8 : 518-24. [Google Scholar]
  33. Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007 ; 51 : 3471-84. [Google Scholar]
  34. Desphande P, Rodrigues C, Shetty A, et al. New Delhi metallo β-lactamase (NDM-1) in Enterobacteriaceae; treatment options with carbapenems compromised. J Assoc Physicians India 2010 ; 58 ; 1-6. [Google Scholar]
  35. Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 2010 ; 65 : 2253-4. [Google Scholar]
  36. Poirel L, Lagrutta E, Taylor P, et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010 ; 54 : 4914-6. [Google Scholar]
  37. Zahar JR, Bille E, Schnell D, et al. Diffusion communautaire des entérobactéries sécrétrices de P-lactamase à spectre élargi (EBLSE). Med Sci (Paris) 2009 ; 25 : 939-44. [Google Scholar]
  38. Pagès JM. Porines bactériennes et sensibilité aux antibiotiques. Med Sci (Paris) 2004 ; 20 : 346-51. [Google Scholar]
  39. Barbier F, Wolff M. Multirésistance chez Pseudomonas aeruginosa. Vers l’impasse thérapeutique ? MedSci (Paris) 2010 ; 26 : 960-8. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.